Department of Anthropology, University of Massachusetts, Amherst, Massachusetts, USA.
Instituto de Investigación Nutricional, La Molina, Lima, Peru.
Am J Phys Anthropol. 2021 Sep;176(1):54-65. doi: 10.1002/ajpa.24287. Epub 2021 Apr 14.
Peruvians are experiencing rapid dietary and lifestyle changes, resulting in a phenomenon known as the "dual burden of disease." A common manifestation of the dual burden in individuals is the co-occurrence of overweight and anemia. Despite recent initiatives introduced to address these concerns, rates continue to be public health concerns. This study investigates the relationship between immune activation and lack of response to iron supplementation after 1 month of treatment and explores variation in body fat stores as a potential moderator between immune function and response to treatment.
Data come from children, aged 2-5 years (n = 50) from a peri-urban community in Lima, Peru. Multivariate logistic regression models were used to explore the associations between response to treatment (Hb > =11.0 g/dl) after 1 month of treatment), markers of immune activation (C-reactive protein [CRP] and reported morbidity symptoms), and measures of body fat (waist-to-height ratio, triceps skinfold thickness, and body mass index [BMI]).
We found that high CRP is associated with a lack of response to iron supplementation after 1 month of treatment and that BMI z-score may moderate this association. Generally, larger body size is associated with response to iron supplementation whether or not the children in this sample have high immune activation. However, the probability of anemic children responding to iron supplementation treatment differed across adiposity measures.
Our finding suggesting that adiposity and CRP influence response to iron supplementation, furthers our understanding of the relationship between inflammation and anemia treatment in children and has both theoretical and public health implications.
秘鲁人正经历着快速的饮食和生活方式的改变,导致了一种被称为“双重疾病负担”的现象。双重疾病负担在个体中的一个常见表现是超重和贫血同时存在。尽管最近采取了一些措施来解决这些问题,但这些问题仍然是公共卫生关注的焦点。本研究调查了免疫激活与治疗 1 个月后对铁补充剂无反应之间的关系,并探讨了体脂肪储存的变化作为免疫功能与治疗反应之间的潜在调节因素。
数据来自秘鲁利马一个城市周边社区的 2-5 岁儿童(n=50)。使用多变量逻辑回归模型来探讨治疗 1 个月后(Hb≥11.0g/dl)的治疗反应与免疫激活标志物(C 反应蛋白[CRP]和报告的发病症状)以及体脂肪测量指标(腰高比、三头肌皮褶厚度和体重指数[BMI])之间的关系。
我们发现高 CRP 与治疗 1 个月后对铁补充剂无反应有关,而 BMI z 评分可能调节这种关联。通常,较大的体型与铁补充剂的反应有关,无论样本中的儿童是否存在高免疫激活。然而,肥胖指标不同的贫血儿童对铁补充剂治疗的反应概率也不同。
我们的发现表明,肥胖和 CRP 影响对铁补充剂的反应,这进一步加深了我们对炎症与儿童贫血治疗之间关系的理解,具有理论和公共卫生意义。